Sowa Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-130
Closed -$14K 73
2020
Q4
$14K Hold
130
0.01% 212
2020
Q3
$11K Hold
130
0.01% 214
2020
Q2
$13K Hold
130
0.01% 206
2020
Q1
$10K Hold
130
0.01% 205
2019
Q4
$12K Buy
+130
New +$10.8K 0.01% 210

Other funds holding ABBV

Sowa Financial Group's ABBV Position: Q1 2021 in Review

Sowa Financial Group sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 130 shares — an estimated $14K sold.

Sowa Financial Group first reported a position in ABBV in Q4 2019 and held it in 5 quarters. The position peaked at $14K in Q4 2020. 2,614 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • Sowa Financial Group reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
  • Sowa Financial Group sold 130 AbbVie shares in Q1 2021, an estimated $14K.
  • Sowa Financial Group first reported a position in AbbVie in Q4 2019 and held it in 5 quarters.
  • Sowa Financial Group's AbbVie position peaked at $14K in Q4 2020.
  • 2,614 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Sowa Financial Group's 13F filing for Q1 2021, filed 7 Apr 2021.